Mario Gabelli Dexcom Inc Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Dexcom Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 52,000 shares of DXCM stock, worth $4.17 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

52,000

Previous 52,000 -0.0%

Holding current value

$4.17 Million

Previous $5.9 Million 40.88%

% of portfolio

0.04%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $2.65 Million - $5.18 Million	39,000 Added 300.0%	52,000 $3.88 Million
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $23,400 - $31,350	-300 Reduced 2.26%	13,000 $4.81 Million
Q3 2020 Nov 06, 2020	SELL	$95.51 - $112.95 $19,102 - $22,590	-200 Reduced 1.48%	13,300 $5.48 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $31,340 - $52,670	-500 Reduced 3.57%	13,500 $5.47 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $142,818 - $223,431	-3,900 Reduced 21.79%	14,000 $3.06 Million
Q3 2019 Nov 01, 2019	SELL	$35.53 - $43.8 $39,083 - $48,180	-1,100 Reduced 5.79%	17,900 $2.67 Million
Q2 2019 Aug 02, 2019	SELL	$27.84 - $38.92 $27,840 - $38,920	-1,000 Reduced 5.0%	19,000 $2.85 Million
Q1 2019 May 02, 2019	SELL	$28.07 - $38.18 $14,035 - $19,090	-500 Reduced 2.44%	20,000 $2.38 Million
Q4 2018 Jan 30, 2019	SELL	$26.99 - $37.37 $94,465 - $130,794	-3,500 Reduced 14.58%	20,500 $2.46 Million
Q3 2018 Nov 02, 2018	SELL	$23.35 - $36.72 $23,350 - $36,720	-1,000 Reduced 4.0%	24,000 $3.43 Million
Q2 2018 Aug 10, 2018	SELL	$17.54 - $25.22 $122,780 - $176,540	-7,000 Reduced 21.88%	25,000 $2.38 Million
Q3 2017 Nov 01, 2017	BUY	$11.36 - $18.98 $363,520 - $607,360	32,000	32,000 $1.57 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account